BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Policy

  Veritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing Facility

  Veritas is also issuing to 906474 Special Warrant Shares which would entitle 906474 to additional shares of Veritas equal to $800,000 less the current market price of the Veritas Shares times the market price on the last trading day immediately following the 4 month holding period.

  November 20, 2017

   · 

  3 min read
• Biotech Bay

  CareDx: CMS Releases 2018 Clinical Laboratory Fee Schedule

  This confirms that the AlloMap reimbursement rate will be increased to $3,240.

  November 20, 2017

   · 

  2 min read
• Business

  bionorthTX’s iC3 Summit Grows Popular Hub in North Texas for Life Sciences Companies

  The North Texas region has become a popular destination for Life Sciences companies

  November 20, 2017

   · 

  3 min read
• Business

  IBEX Reports Results for the Year Ended July 31, 2017

  Revenues for the year ended July 31, 2017 totaled $5,326,721 compared to $4,113,694 in the prior year.

  November 20, 2017

   · 

  5 min read
• Business

  India Globalization Capital Reports Second Quarter 2018 Financial Results and Operational Highlights

  Cost of revenue for the three months ended September 30, 2017 was $163,170 as compared to $90,534 for the three months ended September 30, 2016.

  November 20, 2017

   · 

  8 min read
• Business

  Johnson & Johnson Medical Devices Companies Unveils State of the Art “Engineering Studio” at Texas Medical Center to Accelerate Medical Devices Development

  Housed within the TMC Innovation Institute, the 26,000-square-foot facility will host JJMDC R&D staff working on select internal projects along with strategically aligned external ventures of JJMDC.

  November 20, 2017

   · 

  4 min read
• Business

  Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results

  Fourth-quarter GAAP net income was $177 million, or $0.54 per share. Last year’s fourth-quarter GAAP net income was $126 million, or $0.38 per share.

  November 20, 2017

   · 

  21 min read
• Cellectis Demonstrates Fine and Predictable Tuning of TALEN Gene Editing Targeting to Improve T-cell Adoptive Immunotherapy

  In this report, Anne-Sophie Gautron, Ph.D., Alexandre Juillerat, Ph.D., and their collaborators used a strategy developed by Cellectis to control TALEN targeting based on a proprietary technology leveraging the exclusion capacities of non-conventional RVDs.

  November 20, 2017

   · 

  4 min read
• 

  Deals

  AmerisourceBergen Pays $815M Cash for Drug Wholesaler H. D. Smith

  AmerisourceBergen expects the transaction to slightly add to its adjusted earnings per share in the current fiscal year.

  November 20, 2017

   · 

  11 min read
• Beleave Announces $5M Non-Brokered Private Placement of Units

  The Company may, as a result, increase the size of the Non-Brokered Offering by up to 20%, for aggregate gross proceeds of approximately $6 million.

  November 20, 2017

   · 

  3 min read